Cytosorbents Crp Stock Alpha and Beta Analysis
| CTSO Stock | USD 1.10 0.03 2.80% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Cytosorbents Crp. It also helps investors analyze the systematic and unsystematic risks associated with investing in Cytosorbents Crp over a specified time horizon. Remember, high Cytosorbents Crp's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Cytosorbents Crp's market risk premium analysis include:
Beta 0.0508 | Alpha 0.28 | Risk 5.13 | Sharpe Ratio 0.0783 | Expected Return 0.4 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Cytosorbents |
Cytosorbents Crp Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Cytosorbents Crp market risk premium is the additional return an investor will receive from holding Cytosorbents Crp long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Cytosorbents Crp. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Cytosorbents Crp's performance over market.| α | 0.28 | β | 0.05 |
Cytosorbents Crp expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Cytosorbents Crp's Buy-and-hold return. Our buy-and-hold chart shows how Cytosorbents Crp performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Cytosorbents Crp Market Price Analysis
Market price analysis indicators help investors to evaluate how Cytosorbents Crp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cytosorbents Crp shares will generate the highest return on investment. By understating and applying Cytosorbents Crp stock market price indicators, traders can identify Cytosorbents Crp position entry and exit signals to maximize returns.
Cytosorbents Crp Return and Market Media
The median price of Cytosorbents Crp for the period between Sat, Dec 14, 2024 and Fri, Mar 14, 2025 is 1.01 with a coefficient of variation of 9.99. The daily time series for the period is distributed with a sample standard deviation of 0.1, arithmetic mean of 1.01, and mean deviation of 0.07. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | CytoSorbents Rights Offering Begins | 12/23/2024 |
2 | CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue | 01/03/2025 |
3 | CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights Offering | 01/13/2025 |
4 | Cytosorbents Research Coverage Started at StockNews.com | 01/24/2025 |
5 | AVENIR CORPs Strategic Acquisition of CytoSorbents Corp Shares | 02/14/2025 |
6 | Disposition of 21950 shares by Sobel Alan D. of Cytosorbents Crp at 1.13 subject to Rule 16b-3 | 02/24/2025 |
7 | CytoSorbents Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right Warrants | 02/25/2025 |
8 | Cytosorbents Corporation Strengthens Balance Sheet With Successful Exercise of Series A Right Warrants | 02/26/2025 |
9 | CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller | 03/04/2025 |
10 | CytoSorbents Corp Q4 2024 Earnings Report Preview What To Expect | 03/05/2025 |
11 | Acquisition by Bator Michael G. of 44000 shares of Cytosorbents Crp at 0.955 subject to Rule 16b-3 | 03/07/2025 |
12 | Cytosorbents shareholders have endured a 78 percent loss from investing in the stock five years ago | 03/10/2025 |
About Cytosorbents Crp Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Cytosorbents or other stocks. Alpha measures the amount that position in Cytosorbents Crp has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2024 | 2025 (projected) | Dividend Yield | 0.002151 | 0.002043 | Price To Sales Ratio | 1.57 | 1.49 |
Cytosorbents Crp Upcoming Company Events
As portrayed in its financial statements, the presentation of Cytosorbents Crp's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cytosorbents Crp's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Cytosorbents Crp's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Cytosorbents Crp. Please utilize our Beneish M Score to check the likelihood of Cytosorbents Crp's management manipulating its earnings.
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 7th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Cytosorbents Crp
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Cytosorbents Crp Backtesting, Cytosorbents Crp Valuation, Cytosorbents Crp Correlation, Cytosorbents Crp Hype Analysis, Cytosorbents Crp Volatility, Cytosorbents Crp History and analyze Cytosorbents Crp Performance. To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Cytosorbents Crp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.